Editorial: Genetic/epigenetic mechanisms and related clinical strategy in leukemia

Frontiers in Oncology

Oncology

Yonghui Li¹  Liping Dou²  Clara Nervi³ 

[1]Central Laboratory, Shenzhen Key Laboratory of Precision Medicine for Hematological Malignancies, Shenzhen University General Hospital, Shenzhen University Health Science Center, Shenzhen, Guangdong, China

[2]Department of Hematology, People’s Liberation Army General Hospital, Beijing, China

[3]Department of Medical and Surgical Sciences and Biotechnologies, Sapienza University of Rome, Rome, Italy

关键词: leukemia;    epigenetics;    genetics;    t(8;    21) AML;    miRNAs;    COVID-19;   

DOI  :  10.3389/fonc.2023.1275992

 received in 2023-08-11, accepted in 2023-08-14,  发布年份 2023

来源: Frontiers

【 授权许可】

Unknown   
Copyright © 2023 Li, Dou and Nervi